Insider buying last 90 days
No open-market insider purchases were filed for XNCR in the last 90 days.
From Form 4 filings, dated to when each was filed.
Oct 12 close
Xencor draws mixed analyst attention this week: Argus lowered its target price for the stock to $19.00 on October 7, even as the shares traded at $24.63 at the time. Separately, commentary on the stock describes a near-term strong sentiment giving way to mid-term neutrality with a longer-term positive bias, reflecting differing read on the same price action rather than new company news.
XNCR closed at $25.04, up 1.7%, sitting above both its 50-day average of $24.74 and its 200-day average of $16.15, with the shorter average above the longer one. The GekkoIndex reads 58.1, placing the stock in the Neutral zone. Against a Gekko Fair Value of $27.35, the current price sits 8.4% below that level. Twelve-month return stands at 91.7%, with six-month gains of 107.5% and three-month gains of 67.5%.
Earnings are scheduled for 4 November, 22 days out, falling inside a typical 20-trading-day holding window; the prior report on 5 August showed an actual EPS of -0.29 against an estimate of -0.8, with a 0.4% reaction, and six beats across the last eight quarters. No insider, Congress, or unusual options activity appears in the respective 90-day and 30-day windows. Seasonality over five years shows an average 20-day return of 6.1% from this point in the calendar, with gains in four of those years. Analyst coverage includes 13 firms, 11 at buy and 2 at hold, with a consensus target of $31.42.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
Xencor scores 3 supportive, 1 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed1 headwind
Above 50 and 200-day
Close $25.04 is above the 50-day ($24.74) and 200-day ($16.15) averages, and the 50-day is above the 200-day.
See the chart58.1, Neutral
Reading 58.1 is in the Neutral zone.
See the GekkoIndex8.4% below
Price is 8.4% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 23 days
Reports on Nov 4, 2026, 23 days away — inside a typical 20-trading-day hold.
See earnings+6.1% on average
From this point in the calendar, the next 20 trading days averaged +6.1% over 5 years, rising in 4 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Xencor closed at $25.04 on Oct 12, 2026, +91.7% over the past year, inside a 52-week range of $10.38 to $30.61.
Use the left and right arrow keys to read daily values.
Put XNCR on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Xencor’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 58.1, in the Neutral zone, up 4 points over five sessions.
Up 4 points over five sessions.
Reading for Oct 12, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 79 | +0.3% | +2.5% | ||
| Accumulation | 205 | −0.6% | −1.2% | ||
| Neutral (current zone) | 328 | +1.0% | +3.5% | ||
| Distribution | 69 | +2.4% | +8.8% | ||
| Selling | 1 | Too few readings yet | |||
Average XNCR share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Xencor trades 8.4% below Gekko Fair Value of $27.35, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Xencor shares are worth, recalculated every trading day.
$27.35
Gekko Fair Value, Oct 10, 2026
8.4% Undervalued
At the end of Aug 2026 the price was 5.4% above the estimate.
No open-market insider purchases were filed for Xencor, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for XNCR in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in XNCR were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
0of the funds Gekko tracks hold XNCR.
Xencor reports on Nov 4, 2026 (23 days away), and beat the EPS estimate in 6 of its last 8 reports.
Nov 4, 2026
23 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 5, 2026 | −$0.29 est −$0.80 | $51.22M est $18.89M | +0.4% |
| May 6, 2026 | −$1.71 est −$0.75 | $4.52M est $27.86M | −4.2% |
| Feb 25, 2026 | −$0.09 est −$0.60 | $28.24M est $29.96M | +14.7% |
| Nov 5, 2025 | −$0.08 est −$0.72 | $21.00M est $29.97M | +2.2% |
| Aug 6, 2025 | −$0.41 est −$0.78 | $43.61M est $24.37M | −7.9% |
| May 7, 2025 | −$0.66 est −$0.63 | $32.73M est $22.49M | +3.9% |
| Feb 27, 2025 | −$0.62 est −$0.79 | $70.02M est $16.94M | +6.8% |
| Nov 6, 2024 | −$0.71 est −$1.02 | $10.71M est $16.62M | +7.7% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Xencor is $31.42, +25.5% from the last close, from 13 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 13 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 29 | Wells Fargo | $30 | +19.8% |
| Sep 28 | Truist Financial | $29 | +15.8% |
| Sep 25 | Wedbush | $30 | +19.8% |
| Sep 21 | Bank of America Securities | $26 | +3.8% |
| Sep 21 | Bank of America Securities | $26 | +3.8% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Oct 10, Xencor averaged +6.1% across the last 5 years, rising in 4 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +7.1% | 3 of 5 |
| Next 10 trading days | +2.7% | 4 of 5 |
| Next 15 trading days | +5.4% | 4 of 5 |
| Next 20 trading days | +6.1% | 4 of 5 |
| Next 30 trading days | +10.3% | 3 of 5 |
For scale, XNCR’s typical 20-trading-day move in either direction is about 10.6%.
Xencor’s market cap is $1.86B and revenue of $105.0M over the last twelve months.
2 headlines about Xencor from the past week, newest first, each linking to the publisher.
Xencor’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| AMGNAmgen | Neutral | 25.5% below |
| GILDGilead Sciences | Neutral | 4.2% above |
| MRNAModerna | Neutral | 62.7% above |
| NTRANatera | Neutral | 10.3% above |
| IQVIQVIA | Neutral | 8.4% above |
| UTHRUnited Therapeutics | Neutral | 14.4% below |
A peer links to its own page where one exists.
Xencor’s market cap is $1.86B at the Oct 12, 2026 close of $25.04, with 74.35M shares outstanding.
The consensus analyst 12-month price target for Xencor is $31.42, +25.5% from the last close. Of the 13 firms that rated the stock in the last 90 days, 11 rate it a buy, 2 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Xencor is undervalued: the Oct 12, 2026 close of $25.04 is 8.4% below Gekko Fair Value of $27.35. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Xencor is expected to report on Nov 4, 2026 (23 days away). Analysts expect earnings of −$0.38 per share on revenue of $59.08M. Xencor beat the earnings estimate in 6 of its last 8 reports, moving 6% on average across the report.
Xencor’s 52-week high is $30.61 and its 52-week low is $10.38; it closed at $25.04 on Oct 12, 2026, +91.7% over the past year. Over the last five years the shares peaked at $43.61 on Nov 3, 2021.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (trend, fair value and seasonality), 1 as mixed (gekkoindex) and 1 as a headwind (earnings risk). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.